Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 64

Sort by

Sort Order Select

Journal Articles

Nanobody-based Naturally Selected CD7-Targeted CAR-T Therapy for Acute Myeloid Leukemia

Peihua Lu, Xian Zhang, Junfang Yang, Jingjing Li, Liyuan Qiu, Meiwei Gong, Hui Wang, Jiaqi Chen, Hongxing Liu, Min Xiong, Ying Liu, Lin Wang

Blood blood.2024024861.

https://doi.org/10.1182/blood.2024024861

Published: 2024

Includes: Supplemental data

Journal Articles

Prophylactic Basiliximab on Days +1 and +4 Post-Haploidentical Hematopoietic Stem Cell Transplantation Reduces Incidence of Grade II-IV Acute Graft-Versus-Host Disease in Acute Myeloid Leukemia Patients in Complete Remission (M1, M2, and M4 Subtypes)

Zhijie Wei, Fei Pan, Jing Long, Zheren Wang, Guanlan Yue, Kang Gao, Kun Wang, Huili Zhu, Yujie Wang, Peihua Lu

Blood (2024) 144 (Supplement 1): 7363.

https://doi.org/10.1182/blood-2024-206773

Published: 2024

Journal Articles

Busulfan-Based Intensified Myeloablative Conditioning Regimen Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia-Single Center Study

Yun Wang, Ruijuan Sun, Yanli Zhao, Zhijie Wei, Min Xiong, Deyan Liu, Peihua Lu, Yue Lu

Blood (2024) 144 (Supplement 1): 7328.

https://doi.org/10.1182/blood-2024-202905

Published: 2024

Journal Articles

Safety and Efficacy of CD 19 CAR T Cells (S1904) in Patients with RR B-ALL: A Pooled Analysis of Two Early-Phase Trials

Xiao Jun Huang, Meng Lv, Peihua Lu, Jianmin Luo, Na Kuang

Blood (2024) 144 (Supplement 1): 7207.

https://doi.org/10.1182/blood-2024-202170

Published: 2024

Journal Articles

CD7-Targeted CAR-T Cell Therapy Shows Promising Efficacy and Safety in Treating Refractory/Relapsed Peripheral T-Cell Lymphoma: Phase I Clinical Trial

Junfang Yang, Xian Zhang, Jingjing Li, Liyuan Qiu, Lin Wang, Peihua Lu

Blood (2024) 144 (Supplement 1): 2075.

https://doi.org/10.1182/blood-2024-196853

Published: 2024

Journal Articles

Improved Outcomes with Bu/Cy+Melphalan and Bu/Cy+Thiotepa Regimens in Haploidentical Hematopoietic Stem Cell Transplantation for Non-Down Syndrome Acute Megakaryoblastic Leukemia

Zhijie Wei, Fei Pan, Jing Long, Guanlan Yue, Kang Gao, Kun Wang, Huili Zhu, Yujie Wang, Zheren Wang, Peihua Lu

Blood (2024) 144 (Supplement 1): 3492.

https://doi.org/10.1182/blood-2024-206814

Published: 2024

Journal Articles

Comparable OS and Gffs of ATLG Vs. Ratg for Gvhd Prophylaxis in Pediatric AA Patients Undergoing Transplantation

Li Nannan, Yue Lu, Deyan Liu, Min Xiong, Yanli Zhao, Ruijuan Sun, Zhijie Wei, Xingyu Cao, Jiarui Zhou, Jianping Zhang, Peihua Lu

Blood (2024) 144 (Supplement 1): 3537.

https://doi.org/10.1182/blood-2024-209027

Published: 2024

Journal Articles

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for 532 Patients with KMT2A-Rearranged Acute Leukemia

Ruijuan Sun, Yue Lu, Jian-Ping Zhang, Jiarui Zhou, Deyan Liu, Yanli Zhao, Zhijie Wei, Min Xiong, Xingyu Cao, Peihua Lu

Blood (2024) 144 (Supplement 1): 3546.

https://doi.org/10.1182/blood-2024-206907

Published: 2024

Journal Articles

Relapsed/Refractory AML1::ETO Acute Myeloid Leukemia Was Successfully Treated By Allogeneic Hematopoietic Stem Cell Transplantation with Modifyed Myeloablative Preconditioning Contains Olaparib

Song Xue, Peihua Lu, Xingyu Cao

Blood (2024) 144 (Supplement 1): 7321.

https://doi.org/10.1182/blood-2024-209573

Published: 2024

Journal Articles

Combining Melphalan or Thiotepa with an Intensive Conditioning Regimen Significantly Reduces Relapse Rates in Minimal Residual Disease-Positive (MRD+) Pediatric Acute Myeloid Leukemia Patients Post Haploidentical Hematopoietic Stem Cell Transplantation

Huili Zhu, Zhijie Wei, Peihua Lu

Blood (2024) 144 (Supplement 1): 6170.

https://doi.org/10.1182/blood-2024-210032

Published: 2024

Journal Articles

A Novel Full-Spectral Flow Cytometric Assay for Detection of Measurable Residual Disease in Patients with B-Lymphoblastic Leukemia

Ke Li, Man Chen, Meiwei Gong, Peihua Lu, Hui Wang

Blood (2024) 144 (Supplement 1): 5911.

https://doi.org/10.1182/blood-2024-203516

Published: 2024

Journal Articles

A Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Xingyu Cao, Yue Lu, Jian-Ping Zhang, Deyan Liu, Zhijie Wei, Yanli Zhao, Jiarui Zhou, Min Xiong, Ruijuan Sun, Jing Long, Peihua Lu

Blood (2024) 144 (Supplement 1): 4934.

https://doi.org/10.1182/blood-2024-204579

Published: 2024

Journal Articles

Clinical and Immunological Characteristics of Patients with CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Man Chen, Wei Zhao, Minjing Fu, Peihua Lu, Hui Wang

Blood (2024) 144 (Supplement 1): 4874.

https://doi.org/10.1182/blood-2024-199678

Published: 2024

Journal Articles

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Blood (2024) 144 (14): 1471–1485.

https://doi.org/10.1182/blood.2024023883

Published: 2024

Includes: Supplemental data

Journal Articles

Comparative Analysis of Immune Effector Cell-Associated Hematotoxicity (ICAHT) and Infection Incidence Following CD19-Targeted CAR-T Therapy Versus CD7-Targeted CAR-T Therapy

Xian Zhang, Qinglong Wang, Ying Liu, Junfang Yang, Jingjing Li, Hongxing Liu, Jianqiang Li, Peihua Lu

Blood (2023) 142 (Supplement 1): 6883.

https://doi.org/10.1182/blood-2023-185361

Published: 2023

Journal Articles

CD7 CAR-T Therapy Followed By a Second Transplant for T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Patients Who Relapsed after a Prior Transplant

Xingyu Cao, Jianping Zhang, Yue Lu, Yanli Zhao, Deyan Liu, Min Xiong, Zhijie Wei, Jiarui Zhou, Xian Zhang, Junfang Yang, Hongxing Liu, Peihua Lu

Blood (2023) 142 (Supplement 1): 2155.

https://doi.org/10.1182/blood-2023-186030

Published: 2023

Journal Articles

Naturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Acute Myeloid Leukemia: Phase I Clinical Trial

Xian Zhang, Junfang Yang, Jingjing Li, Liyuan Qiu, Hongxing Liu, Sr., Min Xiong, Jianqiang Li, Peihua Lu

Blood (2023) 142 (Supplement 1): 218.

https://doi.org/10.1182/blood-2023-179086

Published: 2023

Journal Articles

Partner Gene Associated Trinary Fusion and Orchestration of Multiple Molecular Events in Acute Promyelocytic Leukemia with Variant Rara Fusion Genes

Blood (2023) 142 (Supplement 1): 1414.

https://doi.org/10.1182/blood-2023-187869

Published: 2023

Journal Articles

Advances in Acute Myeloid Leukemia Classification: A Comparative Analysis of Who-HAEM4R, Who-HAEM5, and International Consensus Classification

Xue Chen, Lili Yuan, Yang Zhang, Fang Wang, Xiaoli Ma, Jiancheng Fang, Panxiang Cao, Yijun Liu, Zhixiu Liu, Ming Liu, Jiaqi Chen, Xiaosu Zhou, Mingyue Liu, David Jin, Peihua Lu, Hongxing Liu

Blood (2023) 142 (Supplement 1): 1566.

https://doi.org/10.1182/blood-2023-187915

Published: 2023

Journal Articles

The Ingenious Multiple Efficacies of the Integrated Gene Fragment of Torque Teno Mini Virus in Orchestrating Promyelocytic Leukemogenesis Via Hijacking Rara

Blood (2023) 142 (Supplement 1): 1576.

https://doi.org/10.1182/blood-2023-185426

Published: 2023

NARROW

Nanobody-based Naturally Selected CD7-Targeted CAR-T Therapy for Acute Myeloid Leukemia

Prophylactic Basiliximab on Days +1 and +4 Post-Haploidentical Hematopoietic Stem Cell Transplantation Reduces Incidence of Grade II-IV Acute Graft-Versus-Host Disease in Acute Myeloid Leukemia Patients in Complete Remission (M1, M2, and M4 Subtypes)

Busulfan-Based Intensified Myeloablative Conditioning Regimen Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia-Single Center Study

Safety and Efficacy of CD 19 CAR T Cells (S1904) in Patients with RR B-ALL: A Pooled Analysis of Two Early-Phase Trials

CD7-Targeted CAR-T Cell Therapy Shows Promising Efficacy and Safety in Treating Refractory/Relapsed Peripheral T-Cell Lymphoma: Phase I Clinical Trial

Improved Outcomes with Bu/Cy+Melphalan and Bu/Cy+Thiotepa Regimens in Haploidentical Hematopoietic Stem Cell Transplantation for Non-Down Syndrome Acute Megakaryoblastic Leukemia

Comparable OS and Gffs of ATLG Vs. Ratg for Gvhd Prophylaxis in Pediatric AA Patients Undergoing Transplantation

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for 532 Patients with KMT2A-Rearranged Acute Leukemia

Relapsed/Refractory AML1::ETO Acute Myeloid Leukemia Was Successfully Treated By Allogeneic Hematopoietic Stem Cell Transplantation with Modifyed Myeloablative Preconditioning Contains Olaparib

Combining Melphalan or Thiotepa with an Intensive Conditioning Regimen Significantly Reduces Relapse Rates in Minimal Residual Disease-Positive (MRD+) Pediatric Acute Myeloid Leukemia Patients Post Haploidentical Hematopoietic Stem Cell Transplantation

A Novel Full-Spectral Flow Cytometric Assay for Detection of Measurable Residual Disease in Patients with B-Lymphoblastic Leukemia

A Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Clinical and Immunological Characteristics of Patients with CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Comparative Analysis of Immune Effector Cell-Associated Hematotoxicity (ICAHT) and Infection Incidence Following CD19-Targeted CAR-T Therapy Versus CD7-Targeted CAR-T Therapy

CD7 CAR-T Therapy Followed By a Second Transplant for T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Patients Who Relapsed after a Prior Transplant

Naturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Acute Myeloid Leukemia: Phase I Clinical Trial

Partner Gene Associated Trinary Fusion and Orchestration of Multiple Molecular Events in Acute Promyelocytic Leukemia with Variant Rara Fusion Genes

Advances in Acute Myeloid Leukemia Classification: A Comparative Analysis of Who-HAEM4R, Who-HAEM5, and International Consensus Classification

The Ingenious Multiple Efficacies of the Integrated Gene Fragment of Torque Teno Mini Virus in Orchestrating Promyelocytic Leukemogenesis Via Hijacking Rara

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only